
Sign up to save your podcasts
Or


Omicron has caused quite a disruption in both pharma and medtech. Derron Stark EY-Parthenon Partner, Principal, Strategy Transactions, speaks about these supply chain issues.
By Informa Markets4.9
77 ratings
Omicron has caused quite a disruption in both pharma and medtech. Derron Stark EY-Parthenon Partner, Principal, Strategy Transactions, speaks about these supply chain issues.

112,426 Listeners